Chordoid glioma is a rare brain tumor that usually grows slowly. People with chordoid glioma often have headaches, vision changes, memory or thinking problems, and sometimes hormone issues. It is most often found in adults and is located near the third ventricle. Treatment usually involves surgery, and doctors may add radiation if needed. The outlook varies with tumor size and location, but many people do well with careful, long‑term follow‑up.
Overview
Chordoid gliomaSymptoms
Chordoid glioma often causes pressure-like headaches, nausea, and blurred or double vision. Early symptoms of chordoid glioma can also include memory or concentration problems, sleep or mood changes, and hormonal issues like unusual thirst, appetite shifts, or temperature intolerance.
Outlook and prognosis
Many living with chordoid glioma do well long term when the tumor is found early and removed safely. Surgery is the main treatment, often followed by focused radiation if needed. Ongoing MRI follow‑up matters because regrowth and hormone or memory changes can occur.
Causes and risk factors
Chordoid glioma usually stems from a single, acquired change in the PRKCA gene within the tumor; it isn’t inherited. Known risk factors are limited; chordoid glioma most often affects women in midlife. No proven environmental or lifestyle links.
Genetic influences
Genetics likely plays a role in chordoid glioma, though it’s rare and research is limited. Many tumors show changes in the PRKCA gene, which can drive growth. These are usually somatic variants in the tumor, not inherited, so family risk appears low.
Diagnosis
Doctors suspect chordoid glioma using brain MRI or CT, which shows a well-defined mass near the third ventricle. The diagnosis of chordoid glioma is confirmed by surgical biopsy and pathology. Additional hormone and vision tests may guide care.
Treatment and drugs
Treatment for chordoid glioma typically centers on safe surgical removal, often with imaging guidance to protect nearby brain structures. When complete removal isn’t possible, focused radiation can help control remaining tumor. Care teams also manage symptoms like headaches, vision changes, and hormone balance.
Symptoms
With chordoid glioma, early symptoms can include headaches, blurry vision, daytime sleepiness, or changes in thirst and mood. Early symptoms of chordoid glioma are often subtle and easy to mistake for stress or poor sleep. Symptoms vary from person to person and can change over time. Day to day, this can look like more naps, missing details at work, or needing to drink water and use the bathroom more often.
A steady or throbbing ache can build, often worse in the morning or with coughing or bending. Pain may sit behind the eyes or across the temples as pressure inside the head rises.
Queasiness can come with headaches and may peak after waking. Vomiting sometimes brings brief relief when pressure changes.
Blurry or dim vision, double vision, or missing parts of side vision can develop. In chordoid glioma, pressure near the optic pathways can make reading, driving, or navigating steps harder.
Short-term memory slips, slower processing, or trouble concentrating can show up. You might notice small changes at first, like losing track of conversations or misplacing items.
How people usually first notice Chordoid glioma?
Many people first notice chordoid glioma when persistent headaches, worsening over weeks to months, start to interfere with daily life, sometimes paired with nausea or vision changes like blurred or double vision. Because this tumor often grows near the hypothalamus and third ventricle, early signs can also include excessive sleepiness, memory or concentration problems, changes in thirst or urination, or shifts in appetite, weight, or menstrual cycles. For some, the first clue is found on brain imaging done after these symptoms appear, revealing the characteristic mass near the center of the brain.
Types of Chordoid glioma
Chordoid glioma is a rare brain tumor typically arising near the third ventricle. Clinicians often describe them in these categories: by how the tumor looks under the microscope, by its location and size, and by how it behaves over time. There are no widely accepted genetic subtypes; most reported tumors share similar molecular features and grade. In practice, “types of chordoid glioma” usually refers to clinical presentation patterns rather than true genetic variants.
Typical third‑ventricle
Arises from the anterior third ventricle and pushes on nearby structures. Symptoms often include headaches, memory or thinking changes, and vision or hormone-related issues from pressure on the hypothalamus and optic pathways. Early symptoms of chordoid glioma can be subtle and progress slowly.
Suprasellar/optic involvement
Extends toward the suprasellar space and optic chiasm. People may notice blurred vision, reduced visual fields, or light sensitivity, while clinicians may find visual pathway compression.
Predominantly hypothalamic
Centers on or strongly affects the hypothalamus. This pattern can lead to changes in appetite, sleep, temperature tolerance, and hormone balance, sometimes with fatigue or mood shifts.
Large/obstructive hydrocephalus
Tumor size blocks cerebrospinal fluid flow causing hydrocephalus. Symptoms can include worsening headaches, nausea, and balance trouble, and features may include enlarged ventricles on imaging.
Cystic‑solid mix
Shows both cystic and solid components on imaging. People may experience similar pressure-related symptoms, but cyst fluid shifts can cause symptom ups and downs.
Post‑treatment changes
Describes symptoms dominated by effects of surgery, radiation, or targeted therapies rather than the tumor itself. Some may have hormone deficits, memory or attention changes, or fatigue that differ from pre-treatment symptoms.
What genetics can tell you about symptoms
Certain gene changes, especially mutations in PRKCA, can drive chordoid glioma cells to grow, leading to headaches, vision changes, memory problems, and hormonal symptoms like thirst or fatigue. When the tumor presses near the hypothalamus, people may notice temperature swings, sleep issues, or appetite changes.
Causes and risk factors
The main driver appears to be a specific gene change in the tumor cells.
In chordoid glioma this often involves a gene called PRKCA.
Risk factors for chordoid glioma have no confirmed links to lifestyle or environment and the gene change is not inherited.
It tends to occur in middle to later adulthood and is slightly more common in women.
Researchers are still learning how these pieces fit together.
Environmental and biological risk factors
Learning about what may raise the chance of chordoid glioma can help you focus your energy on what’s known and avoid blame for what isn’t. For most people, there are no clear exposures that explain why it occurs. Doctors often group risks into internal (biological) and external (environmental). Understanding these patterns can also guide when to pay attention to early symptoms of chordoid glioma.
Chordoid glioma is most often diagnosed in adults, typically between ages 30 and 60. Children and older adults can be affected, but it is uncommon. Age alone does not predict how the tumor will behave.
This tumor has been reported a bit more often in women. The reason for this pattern is not well understood. Sex does not change the need for prompt evaluation if symptoms arise.
Chordoid glioma almost always starts near the front of the third ventricle deep in the brain. This points to local cell types in that region as part of the biology. It reflects tissue origin rather than something a person does.
No specific environmental exposure has been confirmed to raise risk for chordoid glioma. Research has not tied air pollution, workplace chemicals, or prior infections to this tumor. Studies continue to watch for patterns as more cases are reported.
Genetic risk factors
For most people, Chordoid glioma happens because of a single, acquired gene change inside the tumor cells, not a trait passed down in a family. The same hotspot change in a gene called PRKCA is found in most tumors and likely drives their growth. Current research suggests genetic risk factors for Chordoid glioma center on this tumor-specific change rather than inherited risk. Science continues to uncover how these elements interact.
PRKCA hotspot mutation: Most chordoid gliomas share a single change in the PRKCA gene, often called D463H. This change pushes cells to grow and survive when they normally wouldn’t. It is acquired in the tumor cells, not present in your bloodline.
Growth pathway activation: The PRKCA change overactivates a growth pathway (MAPK/ERK). This overactivity appears central to how the tumor starts and persists. It helps explain why the same gene change shows up so reliably.
Sporadic, not inherited: Chordoid glioma typically occurs without a family pattern. Having relatives with the tumor does not seem to raise your risk. Most people do not carry an inherited mutation related to this tumor.
No known syndromes: There is no confirmed link between Chordoid glioma and a known hereditary cancer syndrome. Doctors rarely find inherited changes when they test blood or saliva. Family history usually does not change medical decisions about genetic risk for this tumor.
Other mutations rare: Aside from PRKCA, consistent additional gene changes have not been shown. When other alterations are reported, they are uncommon and not clearly tied to risk. Research is ongoing because the tumor is rare.
Lifestyle risk factors
Chordoid glioma is not caused by lifestyle, but day-to-day habits can influence symptom burden, treatment tolerance, and recovery. In particular, behaviors that affect weight, sleep, endocrine balance, and neurological symptoms may change how the condition is experienced. Below are practical ways how lifestyle affects Chordoid glioma during and after treatment, highlighting lifestyle risk factors for Chordoid glioma.
Regular, gentle activity can reduce cancer-related fatigue and preserve strength during treatment. Prolonged inactivity can worsen deconditioning, balance issues, and mood.
A nutrient-dense, protein-forward diet supports wound healing and preserves lean mass after surgery or radiation. Highly processed, high-sugar foods may worsen steroid-related blood sugar spikes and energy crashes.
Hypothalamic involvement can predispose to rapid weight gain and metabolic changes. Excess weight may worsen fatigue, sleep apnea, and long-term cardiovascular strain during survivorship.
Irregular or short sleep can aggravate headaches, cognition, and mood in people with third-ventricle tumors. Consistent sleep routines may improve daytime clarity and pain thresholds.
Risk prevention
There’s no proven way to prevent chordoid glioma, because no lifestyle or environmental causes are known. Prevention is about lowering risk, not eliminating it completely. The most practical focus is early recognition and timely diagnosis to reduce complications from pressure inside the skull or hormone imbalance. Getting care with experienced teams can also improve safety and outcomes.
Watch for persistent headaches, worsening vision, sleepiness, nausea, memory or mood changes, and shifts in thirst or urination—these can be early symptoms of chordoid glioma. Noting when they start and how they change over days to weeks helps your doctor spot patterns.
If symptoms persist or escalate, seek a neurological exam and brain MRI. Early imaging can identify chordoid glioma before severe pressure or vision loss develops.
Choose centers experienced with third-ventricle tumors and complex skull base surgery. Teams familiar with chordoid glioma can plan safer approaches and reduce complications.
Ask about checking hormones if you notice extreme thirst, frequent urination, temperature swings, or weight changes. Early endocrine care can prevent dangerous imbalances linked to chordoid glioma and its treatment.
Transmission
Chordoid glioma cannot be caught or passed to others. It is not infectious, and there’s no person-to-person spread through casual contact, sex, blood, or pregnancy. Most cases come from a one-time genetic change that happens only in the tumor cells, not from genes you inherit; genetic transmission of chordoid glioma has not been shown. Families almost never have more than one case, and having a relative with chordoid glioma does not appear to raise your risk in a meaningful way.
When to test your genes
Consider genetic testing if you’re diagnosed with a midline brain tumor suspected to be chordoid glioma, as many tumors carry an actionable PRKCA mutation that confirms the diagnosis. Testing is also helpful when imaging or biopsy findings are unclear, guiding surgery and targeted clinical trials. Discuss it earlier if there’s diagnostic uncertainty or atypical features.
Diagnosis
For many, the first step comes when everyday activities start feeling harder—persistent headaches, trouble focusing, or vision changes bring them to care. Doctors then combine an exam, brain imaging, and tissue testing to confirm a diagnosis. Early and accurate diagnosis can help you plan ahead with confidence. Below are common steps used in how Chordoid glioma is diagnosed.
Your clinician asks about headaches, sleepiness, memory or mood changes, thirst, and vision symptoms. They check strength, balance, eye movements, and reflexes to look for signs of increased pressure or third‑ventricle involvement.
MRI is the key imaging test to locate a mass in the third ventricle and see its relationship to nearby structures. It can show a well-defined, strongly enhancing tumor and whether there is fluid buildup (hydrocephalus). This scan often guides the diagnosis of Chordoid glioma and surgical planning.
A CT can be done quickly if symptoms are urgent, such as severe headache or confusion. It helps detect bleeding, calcifications, and signs of pressure, and can visualize a mass even before MRI is available.
Formal visual field testing checks for blind spots or peripheral vision loss caused by pressure on nearby pathways. An eye exam can also reveal swelling of the optic nerves related to high intracranial pressure.
Stages of Chordoid glioma
Chordoid glioma does not have defined progression stages. This tumor’s course isn’t grouped into set steps; instead, care focuses on its size, its spot in the third ventricle, and the pressure or hormone‑related symptoms it may cause, which can change over time. Diagnosis is usually based on brain MRI and confirmed with tissue testing after surgery or biopsy; early symptoms of chordoid glioma can include headaches, vision changes, memory or sleep problems, or increased thirst and urination. Different tests may be suggested to help map how the tumor affects nearby structures, and follow-up MRI scans are used to monitor for growth or return.
Outlook and prognosis
Looking ahead can feel daunting, but people with chordoid glioma often want clear, practical expectations for the years ahead. This rare brain tumor tends to grow slowly, but its location near the third ventricle can affect hormones, sleep, memory, and appetite. Many people ask, “What does this mean for my future?”, and the answer depends largely on how safely the tumor can be removed and how nearby brain structures respond over time. Surgery is the main treatment; when most or all of the tumor is removed, long‑term control is more likely. If complete removal isn’t possible, focused radiation may help keep it stable for years.
The outlook is not the same for everyone, but careful follow‑up is key because even slow‑growing tumors can recur. Doctors call this the prognosis—a medical word for likely outcomes. Serious risks are usually tied to complications of surgery or swelling around the hypothalamus and optic pathways, which can affect hormone balance, vision, temperature regulation, and memory. Mortality is highest in the period around major surgery; beyond that window, many people live for years, especially when the tumor is controlled and hormone changes are managed. Early symptoms of chordoid glioma, like new headaches, excessive sleepiness, or shifts in thirst and urination, should prompt timely evaluation because early care can make a real difference.
With ongoing care, many people maintain daily routines with adjustments such as scheduled rest, hormone replacement, and regular eye checks. Understanding the prognosis can guide planning and help you and your care team balance treatment benefits with quality of life. Talk with your doctor about what your personal outlook might look like, including the plan for surveillance scans, endocrine follow‑up, and when to consider additional therapy if the tumor changes.
Long-term effects
For many, life after a chordoid glioma centers on managing changes tied to where the tumor sits near deep brain structures that handle memory, hormones, and vision. Long-term effects vary widely, and they depend on tumor size, location, and the type of treatment received. Some issues improve over time, while others can linger or appear years later. Recurrence can happen, especially if the tumor wasn’t fully removed, but many people remain stable for long periods.
Memory lapses, slowed thinking, or trouble with attention can persist. These often relate to the tumor’s impact on the third ventricle and nearby pathways. Some people notice good and bad days.
Changes in thirst, body temperature, sleep-wake cycles, or appetite can occur due to hypothalamic and pituitary effects. Weight gain or loss and altered periods or libido may be long-term. These features may fluctuate over time.
Blurry vision, partial field loss, or difficulty focusing can linger. This stems from pressure near optic pathways next to the third ventricle. Regular demands like reading or screens may feel more tiring.
Fluid buildup around the brain can lead to headaches, imbalance, or thinking changes, sometimes requiring a shunt. Even after treatment, some symptoms can come and go. Walking in crowded places may feel less steady.
How is it to live with Chordoid glioma?
Living with chordoid glioma often means navigating symptoms that creep into daily routines—headaches, memory lapses, fatigue, and sometimes changes in vision or sleep—while also managing the uncertainty that comes with a rare brain tumor. Treatment and follow-up can be demanding, with surgery, surveillance MRIs, and medications that may affect energy, mood, or hormone balance, so pacing the day and planning around appointments becomes part of life. People close to you may notice shifts in attention, mood, or stamina and often take on roles as drivers, note-takers, or advocates during visits, which can strengthen bonds but also bring stress that deserves support. Many find that clear communication, structured routines, and a care team that knows this tumor well help restore a sense of control and protect time for work, relationships, and small daily wins.
Treatment and drugs
Treatment for chordoid glioma focuses on safely removing as much of the tumor as possible while protecting nearby brain structures that control memory, hormones, and vision. Surgeons often use precise techniques such as microsurgery or endoscopic approaches; when complete removal isn’t possible, targeted radiation (like stereotactic radiosurgery) may help control growth. Because chordoid glioma sits close to the hypothalamus and pituitary gland, many people need careful hormone monitoring and replacement, plus medicines that reduce swelling or prevent seizures as needed; medicines that ease symptoms are called supportive therapies. Not every treatment works the same way for every person, so care is typically tailored by a multidisciplinary team that may include neurosurgery, neuro-oncology, endocrinology, and rehabilitation. Ask your doctor about the best starting point for you, including how to plan recovery and long‑term follow‑up.
Non-drug treatment
Care focuses on removing or controlling the tumor and supporting day-to-day function. Alongside medicines, non-drug therapies can build strength, thinking skills, and independence before and after hospital care. Because chordoid glioma sits near areas that guide hormones, vision, memory, and sleep, plans are tailored and often combine several approaches. Teams adjust over time to match your goals and any new needs.
Surgeons aim to remove as much tumor as safely possible. The goal is to ease pressure on nearby brain areas and relieve symptoms.
Highly focused radiation targets the tumor while sparing healthy tissue. It may be used when the tumor is hard to reach or after surgery.
Lower doses of radiation are given over several sessions. This can help control growth when complete removal is not possible.
A coordinated plan supports movement, balance, memory, and daily tasks. Therapists adjust exercises as recovery progresses after chordoid glioma treatment.
Your genes may have an impact on how drugs work for you
Most medicines for chordoid glioma—such as anti-seizure drugs, steroids, or pain control—can act differently depending on genes that affect how your liver enzymes process them. In rare cases, tumor genetics may guide targeted therapies or clinical trial options.
Pharmacological treatments
Medication for chordoid glioma mainly supports surgery and recovery, helps manage symptoms, and addresses hormone changes from pressure on the hypothalamus or pituitary. Not everyone responds to the same medication in the same way. There is no widely proven chemotherapy for this rare tumor, though select targeted drugs may be considered case by case. Your team will tailor medicines to your symptoms, imaging, and any lab changes.
These reduce brain swelling and can ease headaches, nausea, and vision pressure—often the early symptoms of chordoid glioma. They are usually used short term and tapered to limit side effects.
Levetiracetam is commonly used to prevent or treat seizures if they occur, especially around surgery. Other options include lacosamide or valproate when needed.
Desmopressin can treat excessive thirst and urination from diabetes insipidus, while levothyroxine or hydrocortisone may replace low thyroid or adrenal hormones. An endocrinologist helps adjust doses based on symptoms and blood tests.
Trametinib (and occasionally binimetinib) may be considered off-label when tumor testing shows MAPK-pathway activation, such as PRKCA-related changes. Evidence comes from small reports, so benefits and risks are weighed carefully.
Genetic influences
Most chordoid gliomas seem to arise by chance rather than being passed down in families. It’s natural to ask whether family history plays a role. Studies find a recurring, single change in a growth-signal gene in many of these tumors, but this change usually appears only in the tumor cells during a person’s lifetime, not in the cells you were born with. Many families wonder, “is chordoid glioma hereditary?”; current evidence suggests it is not, and close relatives typically do not have an increased risk. Because the gene change is confined to tumor tissue, blood or saliva testing rarely provides answers for relatives, while testing the tumor itself can help confirm the diagnosis and, in some centers, guide research or clinical trial options. If more than one relative has a very similar rare brain tumor, or if you’re unsure about patterns in your family, a genetics consultation can help review your situation.
Is Chordoid glioma genetic?
Genetics likely plays a role in chordoid glioma, though it’s rare and research is limited. Many tumors show changes in the PRKCA gene, which can drive growth. These are usually somatic variants in the tumor, not inherited, so family risk appears low.
Pharmacogenetics—how genetics influence drug effects
For chordoid glioma, both the tumor’s own genetics and your inherited drug‑response genes can influence care. Many tumors carry a characteristic change in the PRKCA gene; finding it can support the diagnosis and, in some centers, help guide conversations about clinical trials if surgery and radiotherapy aren’t enough. When early symptoms of chordoid glioma lead to medicines around brain surgery—such as anti‑seizure drugs, pain relievers, or anti‑nausea treatments—common genetic differences can affect dosing, side effects, and benefit. For example, CYP2C9 and certain HLA‑B types (such as HLA‑B*15:02) can change the safety profile of phenytoin or carbamazepine, and CYP2D6 can alter how well codeine or tramadol work for pain. Alongside medical history and the treatment plan, genetic testing can help tailor supportive drugs or dosing. There are no proven gene‑targeted drug therapies for chordoid glioma itself yet, so most decisions still rely on surgery, radiotherapy, imaging, and how you’re doing overall, while factors like age, other medicines, and liver or kidney function also play a role in how you respond.
Interactions with other conditions
People living with chordoid glioma often navigate overlaps with other health issues because the tumor sits near the hypothalamus and pituitary, areas that help regulate hormones, thirst, sleep, and body temperature. When someone already has a pituitary or thyroid condition, early symptoms of chordoid glioma—such as fatigue, weight changes, or thirst and frequent urination—can blend in and delay recognition. Doctors call it a “comorbidity” when two conditions occur together. Hormone changes from chordoid glioma or its treatment can interact with diabetes, high blood pressure, or high cholesterol, sometimes making these conditions harder to control; steroids used around surgery may temporarily raise blood sugar and blood pressure. Vision problems and headaches from chordoid glioma can also overlap with migraine or eye diseases, and seizure medicines may interact with other prescriptions. Talk with your doctor about how your conditions may influence each other, especially if you see multiple specialists, so your care plan stays coordinated.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden changes in thinking, sleep, and appetite that likely traced back to deep brain tumors. Families and communities once noticed patterns of headaches or vision changes that came with these shifts, though the exact cause was unclear. Looking back helps explain why some tumors near the brain’s center were misread for so long—they sit where many vital signals cross, so symptoms can look like many other conditions.
First described in the medical literature as chordoid glioma in the late 1990s, this tumor was recognized as a distinct entity because of its specific look under the microscope and its location near the third ventricle. Initially understood only through symptoms, later imaging studies showed a well-defined mass in this deep midline area. Surgeons and pathologists realized these tumors tended to grow slowly but could still cause serious problems by blocking fluid flow in the brain, leading to pressure buildup and headaches.
Over time, descriptions became more detailed as MRI became widely available. Reports from neurosurgical centers helped define what doctors now consider the classic appearance and behavior of chordoid glioma. Early case series also highlighted how often people presented with memory changes, fatigue, or vision issues—features that, in hindsight, helped separate chordoid glioma from other nearby tumor types.
Advances in genetics added another chapter. Researchers identified a recurrent change in a gene called PRKCA in many chordoid gliomas, strengthening the idea that this is a unique tumor with a shared biological signature. While treatment still relies mainly on surgery and targeted radiation, these molecular findings offer clues for future therapies and help confirm the diagnosis when the tissue sample is small.
As medical science evolved, care teams refined surgical approaches to reach this deep region more safely. The shift from large open operations to more tailored routes—and better anesthesia and intensive care—lowered risks and improved outcomes. Today, multidisciplinary care draws on lessons from earlier decades: recognize the early symptoms of chordoid glioma, confirm the diagnosis with imaging and pathology, and plan treatment that balances tumor control with protection of memory, hormones, and vision.
Despite evolving definitions, the core understanding has held steady: chordoid glioma is uncommon, often slow-growing, and centered near the third ventricle. Each stage in history has added to the picture we have today, moving from scattered case reports to a clearer roadmap for diagnosis, treatment, and long-term follow-up.